BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 2020
View Archived Issues
Homology initiates IND-enabling studies of novel gene therapy for Hunter syndrome
Read More
Feasibility trial of preoperative ipilimumab/nivolumab in locoregionally advanced urothelial cancer
Read More
Enrollment ongoing in phase I study of ALN-HSD
Read More
IAVI, Merck KGaA and Serum Institute of India collaborate to develop MAbs for COVID-19
Read More
Immutep announces investigator-initiated study of eftilagimod alpha in patients with COVID-19
Read More
Evgen Pharma receives all approvals to initiate STAR trial of SFX-01
Read More
Ultragenyx and Solid Biosciences collaborate to develop new gene therapies for DMD
Read More
First patient dosed in phase Ib/II study of dubermatinib plus decitabine in AML
Read More
Preclinical data presented for UB-612 vaccine against COVID-19
Read More
University of Central Florida patents new antimalarials
Read More
Janssen Pharmaceutica patent describes FFAR4 agonists
Read More
Anadolu Ueniversitesi discloses new compounds for cancer
Read More
Venenum Biodesign synthesizes TREX1 inhibitors
Read More
PhaseBio discontinues VANGARD study of pemziviptadil in patients with COVID-19
Read More
Hangzhou Sumgen Biotechnology discloses new fusion proteins for cancer immunotherapy
Read More
Phase III study of BiondVax's universal flu vaccine candidate M-001 does not meet primary endpoint
Read More
Targeting liver repair with an RSPO mimetic
Read More
LIDDS' NZ-TLR9 demonstrates antitumoral effect in mouse tumor models
Read More
KRAS G12C: Adagrasib holds its own at ENA 2020
Read More
Anelixis begins phase IIa study of AT-1501 in ALS
Read More
IDMC recommends continuation of phase III trial of REX-001 for diabetic CLI
Read More
Subcutaneous lirentelimab demonstrates sustained eosinophil suppression in phase I trial
Read More
